	US 12,297,428 B2
	Compositions for identification of membrane targets for enhancement of T cell activity against cancer
Sidi Chen, Milford, CT (US); Lupeng Ye, New Haven, CT (US); Jonathan Park, Scott AFB, IL (US); Matthew Dong, San Francisco, CA (US); and Ryan D. Chow, San Jose, CA (US)
Assigned to Yale University, New Haven, CT (US)
Appl. No. 17/264,691
Filed by YALE UNIVERSITY, New Haven, CT (US)
PCT Filed Jul. 31, 2019, PCT No. PCT/US2019/044424 § 371(c)(1), (2) Date Jan. 29, 2021, PCT Pub. No. WO2020/028533, PCT Pub. Date Feb. 6, 2020.
Claims priority of provisional application 62/805,585, filed on Feb. 14, 2019.
Claims priority of provisional application 62/713,217, filed on Aug. 1, 2018.
Prior Publication US 2022/0340898 A1, Oct. 27, 2022
Int. Cl. C12N 15/86 (2006.01); A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); C12N 15/11 (2006.01); C12N 15/90 (2006.01)

CPC C12N 15/111 (2013.01) [A61K 40/11 (2025.01); A61K 40/31 (2025.01); A61K 40/42 (2025.01); A61K 40/4204 (2025.01); C12N 15/90 (2013.01); A61K 2239/31 (2023.05); A61K 2239/47 (2023.05); C12N 2310/20 (2017.05); C12N 2800/90 (2013.01); C12Y 204/01155 (2013.01); C12Y 503/04001 (2013.01)]

1 Claim

1. An adeno-associated virus (AAV) vector comprising the nucleic acid sequence set forth in SEQ ID NO: 69,821.